Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Alpha Cognition Inc ACOG

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062... see more

NDAQ:ACOG - Post Discussion

Alpha Cognition Inc > $ACOG - not much movement td
View:
Post by partystocker on Oct 14, 2021 2:48pm

$ACOG - not much movement td

Not a lot of movement or news from $ACOG/$ACOGF today. Price continues to consolidate around $1.33 with support and resistance at $1.27 and $1.40.


Hopefully their presentation at the LD Micro Main Event stirs up some investor interest that can bump this stock out of its current trend!!


Keeping my eye open for the top line results of their ALPHA-1062 drug before the end of the year. 


Current value is at $78.72M.

 
Comment by ferret_ca on Oct 19, 2021 9:46am
a good blurb in the globe investor this morning, an analyst from iAcapital gives it $5 price target and basicaly says it has an exceptionally high probability of success. I initiated a starting position at the open today, looks like a good entry point after the dip yesterday. cheers ferret
Comment by ferret_ca on Oct 19, 2021 4:22pm
well that blurb gave it a nice little boost today, not a lot shares out so it won't take much good news to get things really rolling here, it sounds like this alzheimer drug could go thru trials at a much faster pace due to it's make up (and less side effects than others) than other drugs so things look to me like approval could come quicker than some might think, all jmho.   ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities